Navigating the Expanding Spectrum of Financing
William Blair's Private Capital Markets and Leveraged Finance teams explain the highly flexible bespoke capital solutions available to fund growth, acquisitions, and shareholder liquidity.
Watch the video
William Blair’s Expertise for Business Owners: Webinar Series
William Blair’s Ryan DeVore and Matt Zimmer explore the evolving M&A landscape, preparing for life post-transaction, and more in the Business Owners Forum webinar series.
Learn more
Maximize Your Wealth Strategy With an HSA
A health savings account is a powerful tool that extends beyond managing healthcare costs. Understanding its structure is key to unlocking its full value.
Learn more
William Blair Thinking
-
The Growing Importance of AI in the Revenue Cycle Management Marketplace
William Blair’s group head of healthcare technology and services analyst, Ryan Daniels, explores how artificial intelligence is revolutionizing healthcare revenue cycle management by automating financial workflows, reducing costs, and reshaping the industry’s future for providers and vendors.
-
-
Our Mission, Vision, and Values
At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.
Learn more about our mission, vision, and values
Global Community Partners
We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.
More about our community partners
Our Latest News
-
Aardvark Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
-
-
Unisys Corporation: Initiation of Research Coverage
William Blair initiated research coverage of Unisys Corporation (UIS $2.78), a global IT services and solutions provider that serves more than 700 clients worldwide with over 16,000 employees across digital workplace, cloud application and infrastructure solutions, and enterprise compute offerings.
Join Our Team
Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.
Search our job openings
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights